Microfluidics Market Next Big Thing : Biggest Opportunity of 2021 - Qiagen, Abbott Laboratories, Fluidigm Corporation
The microfluidics market is segmented into in-vitro diagnostics, pharmaceutical, life science research & manufacturing, and therapeutics. The in-vitro diagnostics segment is expected to grow at the highest rate during the forecast period. The large share and high growth of this segment can be attributed to the high adoption of microfluidic techniques in laboratory analytical testing and point-of-care testing, growing demand for point-of-care testing, increasing need for miniaturized and portable diagnostic equipment, and the increasing incidence of chronic diseases.
View full press release